Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by bfwon Nov 10, 2017 4:20pm

110 Views

Post# 26942812

RE:RE:RE:RE:RE:RE:Still No Wuxi Update

Yes.

Another basher whose first post was about Fostemsavir.

That bash backfired so now they are working another angle.

Meanwhile, their partner is trying to give science lessons (but has no real world experience of prescribing medications). They would probably be better off taking English lessons...ou bien ecrire en francais.

It’s actually rather comical.

bfw

Bullboard Posts

Calibre discovers significant gold in Newfoundland